Hormone Replacement Therapy for Women: The Complete Guide

What Is Hormone Replacement Therapy?

Hormone replacement therapy (HRT) — sometimes called menopausal hormone therapy (MHT) — involves supplementing estrogen, progesterone, or both to restore levels that naturally decline during perimenopause and menopause. For millions of women, the resulting hormonal shift triggers hot flashes, night sweats, sleep disruption, mood changes, vaginal dryness, and cognitive fog. HRT may help ease these symptoms and, in some cases, support long-term bone and cardiovascular health.

If you've searched for answers about HRT, you've likely encountered conflicting headlines. The 2002 Women's Health Initiative (WHI) study scared many women off hormone therapy for decades. Since then, a deeper analysis of that data — and two decades of follow-up research — has significantly refined our understanding of who benefits, at what doses, and through which delivery methods. This guide summarizes what the evidence actually says.

Types of Hormone Replacement Therapy

Not all HRT is the same. The right type depends on your symptoms, whether you still have a uterus, your age, and your personal health history.

Estrogen-Only Therapy

Women who have had a hysterectomy can use estrogen alone without a progestogen. Estrogen is available as oral tablets, transdermal patches, gels, sprays, and vaginal rings or creams. Systemic forms reach the bloodstream and address the full range of menopause symptoms. Local vaginal estrogen works only on vaginal and urinary tissues and is often recommended separately for genitourinary symptoms.

Combined Estrogen-Progestogen Therapy

Women with an intact uterus must pair estrogen with a progestogen — either progesterone or a synthetic progestin — to protect the uterine lining from overgrowth (endometrial hyperplasia). Combined HRT may be taken continuously (no monthly bleed) or cyclically (with a scheduled withdrawal bleed).

Bioidentical Hormone Therapy

Bioidentical hormones are chemically identical to those produced by the body. Several FDA-approved products — including estradiol patches and micronized progesterone (Prometrium) — are bioidentical. Compounded bioidentical HRT (cBHRT) is mixed at specialty pharmacies and may be customized by a provider. See our article on bioidentical hormone therapy for a deeper dive into the compounded vs. FDA-approved debate.

Who Is HRT For?

Most major medical societies — including the North American Menopause Society (NAMS) and the Endocrine Society — agree that HRT is appropriate for:

• Women under 60, or within 10 years of menopause onset, with bothersome vasomotor symptoms (hot flashes, night sweats)
• Women with premature menopause (before age 40) or early surgical menopause
• Women at high risk for osteoporosis who cannot tolerate other bone-protective therapies
• Women experiencing genitourinary syndrome of menopause (vaginal dryness, recurrent UTIs, discomfort with intercourse)

HRT is generally not recommended for women with a history of breast cancer, blood clots, unexplained vaginal bleeding, or active liver disease. A licensed provider can evaluate your individual risk profile.

Benefits of HRT: What the Research Shows

Hot Flashes and Night Sweats

Estrogen therapy remains the most effective treatment for vasomotor symptoms. Studies consistently show a 75–90% reduction in hot flash frequency and severity. No non-hormonal treatment approaches the same level of relief, though newer non-hormonal options (fezolinetant, gabapentin) may help women who cannot use hormones.

Sleep Quality

Night sweats are a primary driver of sleep disruption in perimenopause. By reducing vasomotor events, HRT often improves sleep onset, duration, and quality. Some women report continued sleep difficulties even after night sweats resolve — suggesting that estrogen may also have direct effects on sleep architecture.

Bone Health

Estrogen is critical for maintaining bone mineral density. The sharp decline in estrogen after menopause accelerates bone loss and raises fracture risk. Studies show that estrogen therapy can maintain or increase bone density and significantly reduce vertebral and hip fractures. It's one of the most effective interventions for preventing osteoporosis in early menopause.

Mood and Cognitive Function

Many women report mood swings, anxiety, irritability, and difficulty concentrating during perimenopause. Estrogen influences serotonin, dopamine, and acetylcholine systems. While HRT is not a treatment for clinical depression, it may help mood symptoms that are directly tied to hormonal fluctuation. Research on long-term cognitive protection is ongoing, but early use may be associated with a reduced Alzheimer's risk in some women.

Genitourinary Health

Genitourinary syndrome of menopause (GSM) — vaginal dryness, thinning, painful intercourse, increased UTI frequency — affects up to 50% of postmenopausal women and often worsens over time without treatment. Low-dose local vaginal estrogen is highly effective, carries minimal systemic absorption, and is recommended even for breast cancer survivors in many cases (with oncologist guidance).

Risks of HRT: Putting Them in Context

Breast Cancer

The WHI study found a slightly elevated breast cancer risk with combined estrogen-progestogen therapy after 5+ years of use. However, the absolute risk increase was small — about 8 additional cases per 10,000 women per year. Estrogen-only therapy was not associated with increased risk and may even be slightly protective. The type of progestogen matters: micronized progesterone appears to carry a lower risk than synthetic progestins.

Blood Clots and Stroke

Oral estrogen modestly raises the risk of venous thromboembolism (VTE) and stroke. Transdermal estrogen (patches, gels) does not appear to carry the same risk, as it bypasses first-pass liver metabolism. For women with VTE risk factors, transdermal delivery is generally preferred.

Cardiovascular Risk

The WHI's elevated cardiovascular findings were largely in women who started HRT more than 10 years post-menopause. When women start HRT early (within the window of 10 years of menopause), the data suggests a neutral to potentially protective effect on coronary heart disease. This is the basis of the "timing hypothesis."

Choosing Your Delivery Method

The way you take HRT affects both efficacy and risk profile:

• Oral tablets: Convenient, well-studied, but associated with higher clot and stroke risk vs. transdermal
• Transdermal patches: Deliver consistent levels, preferred for women with clot risk or migraines
• Gels and sprays: Applied daily to skin; allow flexible dosing
• Vaginal rings: Systemic (Femring) or local (Estring) — convenient for women wanting quarterly replacement
• Pellets: Subcutaneous implants lasting 3–6 months; used by some compounding pharmacies; not FDA-approved as a delivery method

Monitoring and Duration

There is no universal rule for how long to take HRT. Some women use it for 2–3 years to get through peak menopause symptoms; others take it indefinitely for quality-of-life reasons. Annual review with your provider to reassess risk and benefit is standard of care. Gradually tapering — rather than stopping abruptly — helps prevent symptom rebound.

HRT and Telehealth

Access to knowledgeable HRT providers has historically been limited by geography. Telehealth has changed this equation dramatically. A virtual consultation at Truventa Medical allows you to discuss your symptoms, review your lab work, and get a personalized treatment plan — all from home. Our providers are up to date on current NAMS and Endocrine Society guidelines.

Frequently Asked Questions

Can I start HRT in my 40s during perimenopause?

Yes. Perimenopause can cause significant symptoms years before the final menstrual period. Low-dose HRT during this window is supported by evidence and may provide the best long-term benefit.

Will HRT cause weight gain?

Body composition changes are common at menopause due to estrogen decline — particularly increased abdominal fat. HRT does not cause weight gain and may partially offset this shift. For women struggling with weight after menopause, combining HRT with GLP-1 therapy may offer synergistic benefits.

How long before I feel results?

Hot flashes often improve within 2–4 weeks. Vaginal and urinary symptoms may take 3 months. Bone and mood benefits develop over 6–12 months. Individual response varies.

Summary

Hormone replacement therapy is one of the most studied interventions in women's medicine. When initiated at the right time, with the right formulation, by an informed provider, HRT may significantly improve quality of life, protect bone health, and support metabolic function. The key is individualized care — not a blanket approach. Talk to a licensed provider to learn whether HRT makes sense for you.